Abstract
Epalrestat, a drug for diabetic neuropathy, was able to form a cocrystal with a pharmaceutically acceptable coformer of caffeine. The cocrystal was ch......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
